Hormone Health9 min read·Published November 20, 2026

Hormone Replacement Therapy Pellets: Risks and Options

How pellet implants compare with patches, creams, tablets, and injections for hormone therapy.

Hormone Replacement Therapy Pellets: Risks and Options

Hormone replacement therapy pellets are small implants placed under the skin that release hormone over time. They may suit selected patients, but they are not easily removed or adjusted after placement. The strongest supplied pellet research concerns testosterone in men with hypogonadism, so pellets should not be assumed appropriate for menopause or estradiol treatment 1. Compounded estradiol pellets are not FDA-approved 7.

Wondering if hormone therapy is right for you? Take the 3-min clinical quiz.

See if you qualify →

What are hormone replacement therapy pellets?

Hormone replacement therapy (HRT) pellets are solid implants placed under the skin, usually during an office procedure. A clinician makes a small opening and inserts the pellets into fatty tissue, often near the hip or upper buttock.

Pellets may contain testosterone, estradiol, or both. Testosterone pellets have been studied in men with testosterone deficiency syndrome, also called hypogonadism 1. That evidence does not establish that estradiol pellets work for menopause symptoms or that pellets fit every person.

How pellet implants release hormone

A subcutaneous pellet implant releases hormone gradually as the pellet dissolves. This is why the hormone exposure changes over time rather than acting like a dose that can be changed immediately 3.

What “bioidentical” means

“Bioidentical” describes a hormone with the same chemical structure as a hormone made in the body. The word does not, by itself, show that a product is safer, more effective, or FDA-approved 7.

Why might someone consider hormone pellets?

People often consider pellets because they do not want to apply, swallow, or inject medicine on a frequent schedule. Convenience over several months is a practical benefit, but it is only one part of a treatment decision.

Symptoms such as hot flashes, sleep disruption, low sexual desire, fatigue, or mood changes have many possible causes. A clinician needs to consider the symptom pattern, medical history, medicines, and—when relevant—testing before choosing a hormone or its delivery method 6.

Menopausal hormone therapy and testosterone treatment address different clinical situations. For menopause, hormone therapy decisions depend on symptoms, age, time since menopause, uterus status, and personal risks 6. For possible hypogonadism, a diagnosis requires more than symptoms alone 1.

What does the research say about testosterone hormone pellets?

Testosterone pellets have human research in men with hypogonadism. A randomized clinical trial evaluated testosterone replacement in hypogonadal men, but its findings should not be generalized to estradiol pellets, menopause symptoms, or people without that diagnosis 1.

Human pharmacokinetic research has also examined how testosterone levels change after pellet implantation. Those studies support the basic point that pellet exposure changes over time and is not instantly adjustable after insertion 3.

A single-site retrospective study reported safety observations for Testopel, a testosterone pellet product, in men with testosterone deficiency syndrome. Retrospective findings can describe what happened in one practice, but they cannot prove safety or predict outcomes for every person or pellet formulation 4.

Potential benefits must be weighed against known limits. Testosterone therapy can have side effects and may not be appropriate for people with certain health histories; the right evaluation and follow-up depend on the indication and the individual 6.

What are the possible risks and limitations of hormone pellets?

Pellet extrusion is a documented complication. Extrusion means a pellet works its way out through the insertion site. Randomized studies specifically examined extrusion after testosterone pellet placement 2.

Insertion technique may matter. Research has examined implantation site and track geometry as factors related to extrusion rates and testosterone pellet pharmacology 5.

  • Insertion can cause local pain, bruising, bleeding, infection, or scarring 4.
  • A pellet cannot be simply paused, lowered, or stopped once it is placed under the skin.
  • Follow-up matters because symptoms, side effects, and clinically appropriate lab monitoring can change the treatment plan.
  • A hormone delivery method should fit the medication, reason for treatment, health history, and preference—not convenience alone 6.

How do hormone pellets compare with patches, creams, tablets, and injections?

Pellets offer less day-to-day handling but less dose flexibility. Patches, creams, tablets, and injections can generally be changed or stopped without a pellet insertion or removal procedure. The best route depends on the hormone being considered and your clinical situation 6.

FormHow it is usedMain practical trade-offCan the plan be changed without a procedure?
Pellet implantPlaced under the skin by a clinicianLonger release, but an insertion procedure is neededUsually no; the pellet remains in place
PatchWorn on the skinNo procedure, but requires regular replacementUsually yes
CreamApplied to the skinNo procedure, but requires repeated applicationUsually yes
TabletTaken by mouthNo procedure, but requires regular dosingUsually yes
InjectionGiven under the skin or into muscle, depending on the productNo implant procedure, but involves injectionsUsually yes, at a future dose or prescription change

For menopause care, delivery route can be one part of a larger decision about estradiol and, for people with a uterus who use systemic estrogen, whether progesterone is needed. Our overview of hormone replacement therapy for menopause explains those broader discussions.

Who should discuss hormone therapy options with a clinician?

People considering hormone therapy should discuss options with a clinician before choosing pellets or another form. A clinical evaluation comes before a delivery method because the hormone, indication, and risks matter more than the format alone 6.

  • People with bothersome menopause symptoms who want to discuss menopausal hormone therapy.
  • Men with symptoms that could suggest testosterone deficiency and who need an appropriate evaluation.
  • People with a history of breast or other hormone-sensitive cancer, blood clots, stroke, liver disease, unexplained vaginal bleeding, or cardiovascular risk factors.
  • People taking medicines or supplements that could affect hormone treatment.

If you have chest pain, sudden shortness of breath, one-sided weakness, sudden severe headache, or heavy unexplained bleeding, seek urgent in-person medical care. Those symptoms need prompt assessment rather than an online hormone consultation.

3-min quiz

Compare adjustable hormone therapy options

Chia offers clinician-reviewed estradiol and progesterone options for people whose evaluation supports treatment. A prescription requires a medical evaluation and is not guaranteed. Chia medications are compounded by state-licensed U.S. 503A pharmacies and are not FDA-approved.

What hormone therapy options does Chia offer instead of pellets?

Chia does not offer hormone pellet implantation. For people whose licensed provider is evaluating menopause hormone therapy, Chia offers adjustable estradiol and progesterone forms that do not require a pellet procedure.

Our estradiol options include cream, tablets, a transdermal patch, and injection. Our progesterone options include cream and tablets. The available form is only one part of the decision; a provider considers your reason for treatment, medical history, current medicines, and goals.

Chia optionForms listed in Chia’s catalogPractical consideration
EstradiolCream, tablets, transdermal patch, injectionA provider can assess whether estradiol is appropriate and which listed route fits the treatment plan.
ProgesteroneCream, tabletsA provider can assess whether progesterone is relevant to an estradiol plan and your health history.
Menopause ReliefEstradiol oral plus progesterone IRThis protocol is available only after provider review and is not a pellet alternative for every person.

The Menopause Relief protocol currently combines oral estradiol and progesterone IR. At Chia, you complete a health questionnaire online, then a licensed U.S. provider reviews your information and prescribes only when clinically appropriate. If prescribed, medication is compounded by a state-licensed U.S. 503A pharmacy and shipped to your door.

Provider-guided changes are a practical difference from pellets. You can also read about how to get HRT safely and what people mean by bioidentical hormone replacement therapy before your visit.

How can someone prepare for a hormone therapy consultation?

A useful hormone consultation starts with clear goals and a full health history. Bring a symptom timeline rather than focusing only on a preferred delivery method.

  • List your symptoms, when they began, and how they affect sleep, work, sex, or daily life.
  • Bring all prescription medicines, over-the-counter products, and supplements.
  • Share your menstrual history, pregnancy possibility, surgeries, and personal and family health history.
  • Ask what benefit is realistic, what side effects to watch for, how follow-up works, and when the plan could be adjusted.
  • Ask why a pellet, patch, cream, tablet, or injection is being considered for your specific situation.

A clinician may recommend a different evaluation or an in-person specialist depending on your symptoms and risks. No hormone treatment should be selected from a symptom list alone 6.

3-min quiz

Talk through your hormone therapy options online

If you are considering non-pellet hormone therapy, a Chia provider can review your health information and goals online. Prescriptions are issued only when clinically appropriate and are never guaranteed; Chia medications are compounded by state-licensed U.S. 503A pharmacies.

What are common questions about hormone replacement therapy pellets?

References

  1. 1.Conway AJ, Boylan LM, Howe C, et al. Randomized clinical trial of testosterone replacement therapy in hypogonadal men. International Journal of Andrology. 1988.
  2. 2.Kelleher S, Turner L, Howe C, et al. Extrusion of testosterone pellets: a randomized controlled clinical study. Clinical Endocrinology. 1999.
  3. 3.Handelsman DJ, Conway AJ, Boylan LM. Pharmacokinetics and pharmacodynamics of testosterone pellets in man. Journal of Clinical Endocrinology and Metabolism. 1990.
  4. 4.Cavender RK, Fairall M. Subcutaneous testosterone pellet implant (Testopel) therapy for men with testosterone deficiency syndrome: a single-site retrospective safety analysis. Journal of Sexual Medicine. 2009.
  5. 5.Kelleher S, Conway AJ, Handelsman DJ. Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants. Clinical Endocrinology. 2001.
  6. 6.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.
  7. 7.American College of Obstetricians and Gynecologists. Compounded Bioidentical Menopausal Hormone Therapy: Clinical Consensus. 2023.
  8. 8.U.S. Food and Drug Administration. Testopel (testosterone pellets) prescribing information. 2011.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if hormone therapy is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides